Wednesday, February 10, 2021 12:58:34 PM
Can B Corp and Dr. Karl Zarse Launch ImmuneX2
Can B Corp
Wed, February 10, 2021, 6:00 AM
Targeting Medical Professionals and Direct-to-Consumer Sales Channels to Proactively Optimize Immune Systems
HICKSVILLE, NY, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to announce that its partnership with Dr. Karl Zarse has launched ImmuneX2, a super immune boosting twice a day AM/PM supplement. The two entities have developed a cooperative medical office affiliate program to share in the revenues of ImmuneX2.
According to Dr. Zarse, ImmuneX2 ingredients are correlated with optimizing your immune system before you need it. The certified organic twice a day AM/PM supplement is developed by a physician and prepackaged for convenient dosing.
Can B and Dr. Zarse are now accepting orders for ImmuneX2, available at:
https://www.immunex2.com/immune and https://www.CanbMD.com
Consumers have the option for a monthly subscription with auto-renewal for a discount to the suggested retail price via the ImmuneX2 website.
Pure Health Products, LLC, a subsidiary of Can B, is manufacturing ImmuneX2 for production under Dr. Zarse’s ImmuneX2 label.
Can B will utilize its existing and growing professional medical sales channel that it has built over the past few years with its lineup of other health and wellness branded products, including Duramed and Canbiola to promote ImmuneX2.
Dr. Karl Zarse stated, “It’s been a pleasure working with such a professional team at Can B Corp. and its Pure Health subsidiary. This collaboration has made my dream come true in having an immune boosting system widely available to the public. I think it’s going to be a game changer as to why keeping an optimized immune system is so important in order to live a healthy lifestyle. I look forward to working closely with Can B’s existing sales channels and ever-expanding network to get ImmuneX2 widely distributed and used.”
According to Dr. Zarse, ImmuneX2’s physician developed immunity optimization formula has both innate and adaptive immune functionality specifically targeted with ImmuneX2’s proprietary customer blend focused on immune system optimization. Dr. Zarse further states that “No other product that he is aware of, exceeds the dosages of this blend while avoiding issues of toxicity. ImmuneX2 can compensate for variations in the client base including malabsorption issues, size differences and baseline health status. Maximum benefit is obtained not only by staying adherent to the daily supplement line, but also by following and learning an online education program.”
Dr. Karl Zarse is the founding member of Idaho Spine and Pain. He is certified by the American Board of Interventional Pain Physicians and travels throughout the country to bring his patients the most advanced therapies available. For additional information on Dr. Karl Zarse, please visit: http://www.idahospineandpain.com.
The statements made herein have not been evaluated by the FDA. ImmuneX2 is not intended to diagnose, treat, cure, or prevent any disease.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B is also a license holder of the LifeGuard® Brand in developing a line of consumer products. The Company has launched Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA and Green Grow Farms, a licensed hemp grow and cultivation in New York. To learn more about Can B Corp. and our comprehensive line of high quality CBD products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
•Much success can be attributed to inactivity. Most investors cannot resist the temptation to constantly buy and sell.
•Only buy something that you’d be perfectly happy to hold if the market shut down for 10 years.
Warren Buffett
Recent CANB News
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM